| Name | Title | Contact Details |
|---|
Collington is a Life Care community with so many advantages. We are committed to providing residents with a holistic approach to personal health, wellness and physical well-being. Inspired by the abundance of natural, intellectual and social interaction, Collington provides an active lifestyle of choice, independence and a true sense of community. Here you will be close to the shopping, restaurants and social activities that you are used to being a part of, as well as living in a welcoming, quiet and relaxing home. Collington is ideally situated in close proximity to Washington D.C., Baltimore`s Inner Harbor, Historic Annapolis and the new National Harbor-so you can stay connected to the events and opportunities that interest you, excite you and inspire you. Located on 125 beautifully serene acres, Collington is known for its peaceful campus featuring native trees, rolling lawns, a six-acre lake, walking trails and exquisite gardens. All of this makes for a tranquil surrounding, helping to slow down the pace of everyday life and providing opportunity to enjoy the nature around you. The community features an exceptional selection of apartments and cottages and assures unlimited access to a full continuum of on-site health care services, should you ever need it. Collington is full of international, diverse and active residents involved in pursuing new opportunities in retirement. This stimulating environment is where you will find it easy to get involved with neighbors who share your passion for life! Most retirement communities offer access to health care should you ever need it-with little assurance about cost or availability of care. By contrast, Collington assures its Life Care residents unlimited access to nursing care-including assisted living, recuperative care, memory care and long-term care if needed. This is the true value of Life Care.
MBF Healthcare Partners is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Neuralstem is a dual platform regenerative medicine company. The company`s technology enables the production of regionally specific, physiologically relevant neural stem cells for therapeutic use for the treatment of central nervous system (CNS) diseases and has enabled the discovery of a library of patented small molecule neurogenic compounds to treat psychological and cognitive disorders. Neuralstem`s small molecule drug discovery program screens human neural stem cell lines for compounds that may stimulate neurogenesis in the brain, possibly reversing pathologies associated with certain CNS conditions. The company`s lead compound, NSI-189, has completed FDA Phase Ia and Ib safety trials for the treatment of major depressive disorder (MDD). Neuralstem is expecting to launch a Phase II study for MDD in 2015. Neuralstem`s first stem cell therapy product, NSI-566, a spinal cord-derived neural stem cell line, is in ongoing clinical trials to treat amyotrophic lateral sclerosis (ALS, or Lou Gehrig`s disease), for which it has received orphan status designation by the FDA. Dosing in a phase IIa trial was completed in July, 2014. The next trial is anticipated to commence in 2015. In addition to ALS, the company is conducting an NSI-566 Phase I trial in chronic spinal cord injury, with NSI-566 clinical development also underway to treat ischemic
Dailey Resources Ltd is a Scranton, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
South End Community Health Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Boston, MA. To find more information about South End Community Health Center, please visit www.sechc.org